Ambey Laboratories IPO: All Important Details You Need To Know

  • 26-Jun-2024
  • 2 mins read
Ambey Laboratories IPO

Ambey Laboratories IPO: All Important Details You Need To Know

Ambey Laboratories IPO is open for subscription starting Wednesday, July 3, 2024, and closing on Friday, July 5, 2024. This offer is a book-built issue of 68.64 lakh equity shares. The IPO is a combination of fresh issue and offer for sale. The fresh issue is of 65.52 lakh equity shares and offer for sale of 3.12 lakh equity shares. The allotment for this new IPO is expected to be finalised on Monday, July 8, 2024. Ambey Laboratories IPO will be listed on NSE SME, and the listing date is fixed on Wednesday, July 10, 2024. The price band of this IPO is yet to be announced, and other important details related to lot size and minimum investment are yet to be announced. The book-running lead manager of Ambey Laboratories IPO is Fast Track Finsec Private Limited. The registrar for this IPO is Link Intime India Private Limited. 

Also Read | Avanse Financial Services Initiates ₹3500 Crore IPO: SEBI DRHP Filed

About Ambey Laboratories Limited

Ambey Laboratories Limited was incorporated in 1985 and engaged in the manufacturing of agrochemical products for crop protection. The company has been serving its customers for almost four decades. Ambey Laboratories manufactures and supplies 2,4-D base chemicals. Ambey's manufacturing facility is situated in Behror, Rajasthan. Ambey Laboratories currently produces the following products for its customer base, which includes large corporations like Aromatic Rasayan Private Limited, JR Jindal Infraprojects Private Limited, and SC Formulator Co. As of October 2023, Ambey has a team of 220 members in various departments. 

Objectives of Ambey Laboratories IPO

The amount received from the issue will be used to meet the day-to-day capital needs for the smooth functioning of the company. Additionally, the amount will be used to issue related expenses and fulfil general corporate purposes. 

Financials of Ambey Laboratories Limited (Amt in Rs Lakhs)

Ambey Laboratories posted revenue of Rs 7,005.60 lakhs and net profit of Rs 472.86 lakhs for the period ending on 31 Oct 2023. Earlier, in the period ending on 31 March 2023, the firm reported a revenue of Rs 10,743.47 lakhs and PAT of Rs 456.93 lakhs. The company’s revenue increased by 26.23% and PAT rose by 27.82% between the FY ending on 31st March 2023 and 31st March 2022.

Period Ended

31 Oct 2023

31 Mar 2023

31 Mar 2022

31 Mar 2021

Assets

7,478.42

5,761.85

5,592.94

4,461.80

Revenue

7,005.60

10,743.47

8,511.19

8,241.54

Profit After Tax

472.86

456.93

357.47

1,033.67

Net Worth

3,301.46

2,363.60

1,906.67

-786.39

Reserves and Surplus

1,432.58

588.66

131.73

-1,275.74

Total Borrowing

1,551.29

1,365.22

1,804.86

3,292.98

Other Important Details of Ambey Laboratories IPO

IPO Date

July 3, 2024 to July 5, 2024

Listing Date

July 10, 2024

Face Value

Rs 10 per share

Price

Yet to be announced

Lot Size

2000 Shares

Total Issue Size

6,864,000 shares

Fresh Issue

6,552,000 shares

Offer for Sale

312,000 shares of Rs 10

Issue Type

Book Built Issue IPO

Listing At

NSE SME

Shareholding pre issue

18,688,819

Shareholding post issue

25,240,819

Market Maker portion

312,000 shares

Time-Table of Ambey Laboratories IPO

IPO Open Date

Wednesday, July 3, 2024

IPO Close Date

Friday, July 5, 2024

Basis of Allotment

Monday, July 8, 2024

Initiation of Refunds

July 9, 2024

Credit of Shares to Demat

Tuesday, July 9, 2024

Listing Date

July 10, 2024

Cut-off time for UPI mandate

5 PM on July 5, 2024

IPO Reservation of Ambey Laboratories Limited

Investor Category

Shares Offered

QIB Shares

Not more than 50  percent

Retail Shares

Not less than 35 percent

NII Shares

Not less than 15 percent

Promoters of Ambey Laboratories Limited and Their Holdings

The promoters of Ambey Laboratories company are Archit Gupta, Arpit Gupta, Sarina Gupta and Rishita Gupta.

Shareholding Pre Issue

94.97 percent

Shareholding Post Issue

-

Lead Manager(s) of Ambey Laboratories IPO

The lead manager for Ambey Laboratories IPO is Fast Track Finsec Private Limited.

How do you apply for the Ambey Laboratories IPO?

Wait for the public issue to open for subscription, then click here to apply for the Ambey Laboratories Limited IPO with Bigul.

How do you check the allotment status of Ambey Laboratories IPO?

Link Intime India Private Limited is the registrar for Ambey Laboratories IPO. To check your allotment status, please click here.

FAQs

1. What are the details of the Ambey Laboratories IPO?

This IPO is a book-built issue of 68.64 lakh equity shares. The offer is a combination of fresh issue and offer for sale. The fresh issue is of 65.52 lakh equity shares and offer for sale of 3.12 lakh equity shares. The allotment for this new IPO is expected to be finalised on Monday, July 8, 2024. 

2. Who are the lead managers for the Ambey Laboratories Limited IPO?

Fast Track Finsec Private Limited is appointed as the lead manager for the IPO.

3. What is the role of Link Intime India Private Limited in this IPO?

Link Intime India Private Limited is the registrar for Ambey Laboratories Limited, handling the IPO's administrative aspects.

4. How can I apply for the Ambey Laboratories IPO?

The public subscription of this new IPO will open on July 3, 2024. Click here to initiate the application process.

5. How will the net proceeds from the IPO be utilised?

The amount received from the issue will be used to meet the day-to-day capital needs for the smooth functioning of the company. Additionally, the amount will be used to issue related expenses and fulfil general corporate purposes. 

6. How can I check the allotment status of the IPO?

Investors who applied can check the allotment status of the Ambey Laboratories Limited IPO by visiting here. For further updates follow Bigul. 

7. What is the financial performance of Ambey Laboratories Limited?

Ambey Laboratories posted revenue of Rs 7,005.60 lakhs and net profit of Rs 472.86 lakhs for the period ending on 31 Oct 2023. The company’s revenue increased by 26.23% and PAT rose by 27.82% between the FY ending on 31st March 2023 and 31st March 2022.

Also Read | Budget 2024: Possibility of increase in Standard Deduction Under New Tax Regime


Close

Let's Open Free Demat Account